Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY. | EClinicalMedicine | 2023 | 38033506 | PubTator, text mining | PubMed |
| A Case of Hairy Cell Leukemia Variant: Literature Analysis With Focus on Unmet Needs. | Cureus | 2023 | 38022018 | PubTator, text mining | PubMed |
| Prognostic Potential of Galectin-9 mRNA Expression in Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2023 | 38001630 | PubTator, text mining | PubMed |
| Real-life diagnostic and therapeutic approach to CLL: a 2022 update from an expert panel in Tuscany. | Clin Exp Med | 2023 | 37979127 | PubTator, text mining | PubMed |
| The Role of the Microenvironment and Cell Adhesion Molecules in Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2023 | 37958334 | PubTator, text mining | PubMed |
| Dynamics and durability of HIV-1 neutralization are determined by viral replication. | Nat Med | 2023 | 37957379 | PubTator, text mining | PubMed |
Fixed-duration ibrutinib-venetoclax versus chlorambucil-obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial. | Lancet Oncol | 2023 | 37944541 | PubTator, text mining | PubMed |
| Empirical Study on Exploring the Role of CD180 and MD-1 Prognostic Indicators for the Chronic Lymphocytic Leukaemia (CLL) Disease. | Pak J Biol Sci | 2023 | 37902045 | PubTator, text mining | PubMed |
| Toll-like receptor 9 signaling in chronic lymphocytic leukemia cell lines. | FEBS Open Bio | 2023 | 37881888 | PubTator, text mining | PubMed |
| Unlocking potential inhibitors for Bruton's tyrosine kinase through in-silico drug repurposing strategies. | Sci Rep | 2023 | 37848584 | PubTator, text mining | PubMed |
| Monovalent Omicron COVID-19 vaccine triggers superior neutralizing antibody responses against Omicron subvariants than Delta and Omicron bivalent vaccine. | Hum Vaccin Immunother | 2023 | 37846840 | PubTator, text mining | PubMed |
| Up-Front ASCT Overcomes the Survival Benefit Provided by HDAC-Based Induction Regimens in Mantle Cell Lymphoma: Data from a Real-Life and Long-Term Cohort. | Cancers (Basel) | 2023 | 37835453 | PubTator, text mining | PubMed |
| Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling. | Cancers (Basel) | 2023 | 37835430 | PubTator, text mining | PubMed |
| FCRL1 immunoregulation in B cell development and malignancy. | Front Immunol | 2023 | 37822931 | PubTator, text mining | PubMed |
| Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia. | Sci Rep | 2023 | 37805613 | PubTator, text mining | PubMed |
| Improved computational epitope profiling using structural models identifies a broader diversity of antibodies that bind to the same epitope. | Front Mol Biosci | 2023 | 37790877 | PubTator, text mining | PubMed |
| In-vitro Modulation of mTOR-HIF-1α Axis by TLR7/8 Agonist (Resiquimod) in B-Chronic Lymphocytic Leukemia. | Indian J Hematol Blood Transfus | 2023 | 37786827 | PubTator, text mining | PubMed |
| Serum Paraprotein Is Associated with Adverse Prognostic Factors and Outcome, across Different Subtypes of Mature B-Cell Malignancies-A Systematic Review. | Cancers (Basel) | 2023 | 37760410 | PubTator, text mining | PubMed |
| Atypical Chronic Lymphocytic Leukemia-The Current Status. | Cancers (Basel) | 2023 | 37760396 | PubTator, text mining | PubMed |
| A high-throughput protocol for deamination of long single-stranded DNA and oligo pools containing complex sequences. | STAR Protoc | 2023 | 37742176 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=13